- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 26.11. | Toronto Stock Exchange: VVT Medical Inc. (VVTM) Opens the Market | 228 | Newsfile | Toronto, Ontario--(Newsfile Corp. - November 26, 2025) - Erez Tetro, Chief Executive Officer, VVT Medical Inc. ("VVT", "VVT Medical", or the "Company") (TSXV: VVTM) and his team, joined Dani Lipkin... ► Artikel lesen | |
| 12.11. | VVT Med Inc: VVT Med enters $3.7-million distribution deal in India | 1 | Stockwatch | ||
| 11.11. | VVT Med Signs $3.7 Million Distribution Agreement in India, Achieves European Sales Milestone and Announces Proposed Debt Settlement | 1 | CNW | ||
| 29.10. | VVT Med receives order from NorthWell Health | 1 | Seeking Alpha | ||
| 29.10. | VVT Med Receives Order from Major US Healthcare Network NorthWell Health and Enters Into Investor Relations Agreements | 3 | CNW | ||
| VVT MED Aktie jetzt für 0€ handeln | |||||
| 13.08. | VVT Med Inc: VVT Med hires ITG for market-making services | 1 | Stockwatch | ||
| 13.08. | VVT Med Inc. Engages Independent Trading Group as Market Maker | 2 | CNW | ||
| 31.07. | VVT Med Inc: VVT Med starts trading on TSX-V | 2 | Stockwatch | ||
| 31.07. | VVT Med Inc. Announces Commencement of Trading on TSX Venture Exchange | 2 | CNW | ||
| 23.07. | DXI Capital Corp: DXI Capital closes RTO, changes name to VVT Med | 2 | Stockwatch | ||
| 23.07. | VVT Med Inc. (Formerly DXI Capital Corp.) Completes Reverse Takeover of V.V.T. Med Ltd. and Exiteam Acquisition Corp | 700 | Newsfile | Toronto, Ontario--(Newsfile Corp. - July 22, 2025) - VVT Med Inc. (TSXV: DXI.H) (formerly DXI Capital Corp.) (the "Company") is pleased to announce that it has completed its previously announced acquisition... ► Artikel lesen | |
| 17.07. | DXI Capital Corp: DXI Capital to roll back shares one for 4.67 July 18 | 2 | Stockwatch | ||
| 16.07. | DXI Capital Corp. Effects Share Consolidation and Name Change in Advance of Closing Proposed Reverse Takeover by V.V.T. Med Ltd. and Exiteam Acquisition Corp. | 320 | Newsfile | Toronto, Ontario--(Newsfile Corp. - July 16, 2025) - Further to the transaction update provided in its press release dated June 30, 2025, DXI Capital Corp. (TSXV: DXI.H) ("DXI") is pleased to announce... ► Artikel lesen | |
| 01.07. | DXI Capital Corp: DXI Capital to close RTO by VVT Med within 14 days | 2 | Stockwatch | ||
| 01.07. | DXI Capital Corp. Provides Update on the Proposed Reverse Takeover by V.V.T. Med Ltd. and Exiteam Acquisition Corp. | 573 | Newsfile | Toronto, Ontario--(Newsfile Corp. - June 30, 2025) - DXI Capital Corp. (TSXV: DXI.H) ("DXI") is pleased to provide an update on its proposed acquisition of V.V.T. Med Ltd. ("VVT") and Exiteam Acquisition... ► Artikel lesen | |
| 22.05. | DXI Capital Corp. Files Filing Statement for RTO Transaction | 467 | Newsfile | Toronto, Ontario--(Newsfile Corp. - May 21, 2025) - DXI Capital Corp. (TSXV: DXI.H) ("DXI"), V.V.T. Med Ltd. ("VVT") and Exiteam Acquisition Corp. ("EAC", together with VVT and DXI, the "Parties")... ► Artikel lesen | |
| 25.03. | DXI Capital Corp., V.V.T. Med Ltd. and Exiteam Acquisition Corp. Announce Receipt of TSXV Conditional Approval for RTO Transaction | 608 | Newsfile | Toronto, Ontario--(Newsfile Corp. - March 25, 2025) - DXI Capital Corp. (TSXV: DXI.H) ("DXI"), V.V.T. Med Ltd. ("VVT") and Exiteam Acquisition Corp. ("EAC", together with VVT and DXI, the "Parties")... ► Artikel lesen |
17 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 47,860 | +0,17 % | JPMORGAN stuft Fresenius SE auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Fresenius mit einem Kursziel von 53,60 Euro auf "Overweight" belassen. Die Veranstaltung mit dem Biopharma-Management der Bad... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 44,460 | -0,40 % | Moody's vergibt Investmentgrade-Rating "A3" an Siemens Healthineers | DJ Moody's vergibt Investmentgrade-Rating "A3" an Siemens Healthineers
DOW JONES--Moody's hat Siemens Healthineers die Bonitätsbewertung A3 gegeben, was als sichere Anlage gilt. Der Ausblick ist... ► Artikel lesen | |
| UNITEDHEALTH | 281,00 | -0,51 % | Aktien New York: Verluste - KI-Bedenken rücken wieder in den Vordergrund | NEW YORK (dpa-AFX) - Am US-Aktienmarkt haben am Freitag Bedenken wegen hoher Bewertungen von Tech-Unternehmen die Stimmung belastet. In diesem Umfeld war von dem Schwung nichts mehr zu spüren, den... ► Artikel lesen | |
| DRAEGERWERK | 67,20 | +0,30 % | "Every sip unlocks a story": Sebastian Dräger über die Spirituosen-Manufaktur Copper & Brave | ||
| BOSTON SCIENTIFIC | 81,00 | +0,50 % | UBS bestätigt Kaufempfehlung für Boston Scientific mit Kursziel von 140 US-Dollar | ||
| PLUS THERAPEUTICS | 0,576 | 0,00 % | Plus Therapeutics Inc.: Plus Therapeutics Expands CNSide Assay Platform to State of California | ||
| SPINEWAY | 0,133 | +2,63 % | Spineway: Revenue growth in the third quarter | Ecully, October 14, 2025 - 6:30 p.m. SPINEWAYRevenue growth in the third quarter In thousands of euros20252024Change as a %Q3 revenue3,0452,575 +18%Q2 revenue2,7453,465-21% Q1 revenue2,8283,070-8%9M... ► Artikel lesen | |
| MEDLINE | 40,450 | 0,00 % | Aktien New York: Nasdaq schwach nach starkem Jahr - Medline-Börsengang im Blick | NEW YORK (dpa-AFX) - Die US-Börsen haben am Mittwoch erneut nachgegeben. Die Wall Street und vor allem die technologielastige Nasdaq zollten ihrem starken Lauf im Jahr 2025 weiter Tribut. Sorgen über... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 35,590 | 0,00 % | BrightSpring upgraded at KeyBanc on specialty pharmacy and EBITDA prospects | ||
| HEARTBEAM | 3,060 | 0,00 % | Heartbeam stock is a buy, this analyst says | ||
| PROGYNY | 26,010 | 0,00 % | Progyny, Inc. - 8-K, Current Report | ||
| ALIGNMENT HEALTHCARE | 20,550 | 0,00 % | Alignment Healthcare Reports Third Quarter 2025 Results, Surpasses High-End of Guidance Across All Key Metrics | Reports Q3 revenue of $993.7 million, up 43.5% year-over-yearBeats high end of third quarter guidance and raises full-year outlook across all key metrics: membership, revenue, adjusted gross profit... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,240 | -0,15 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| BETA BIONICS | 29,200 | 0,00 % | Beta Bionics, Inc.: Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance | IRVINE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| GENEDX | 135,46 | 0,00 % | GeneDx and Guardant Health named as BTIG's top picks for 2026 |
Das Unternehmen VVT MED INC kann der Branche Gesundheitswesen zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu VVT MED INC finden Sie auf Wallstreet Online.